Your browser doesn't support javascript.
loading
Implementation of In-Hospital Postpartum Glucose Tolerance Testing for People with Gestational Diabetes.
Ayala, Nina K; Fain, Audra C; Smith, Megan M; Schlichting, Lauren E; Hamel, Maureen S; Werner, Erika F.
Affiliation
  • Ayala NK; Division of Maternal Fetal Medicine, Women and Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, Rhode Island.
  • Fain AC; Department of Obstetrics and Gynecology, David Geffen School of Medicine UCLA, Los Angeles, California.
  • Smith MM; Department of Obstetrics and Gynecology, David Geffen School of Medicine UCLA, Los Angeles, California.
  • Schlichting LE; Division of Maternal Fetal Medicine, Women and Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, Rhode Island.
  • Hamel MS; Hassenfeld Childe Health and Innovation Institute of Brown University, Providence, Rhode Island.
  • Werner EF; Division of Maternal Fetal Medicine, Women and Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, Rhode Island.
Am J Perinatol ; 41(8): 969-974, 2024 06.
Article in En | MEDLINE | ID: mdl-38290557
ABSTRACT

OBJECTIVE:

We aimed to evaluate uptake of the glucose tolerance test performed during delivery hospitalization as part of routine clinical care. STUDY

DESIGN:

This is a retrospective cohort study of people with GDM at a tertiary center. We collected 9 months of postimplementation data after the in-hospital ("early") glucose tolerance test was adopted as a routine screening option. Adherence was compared between those who elected early glucose tolerance testing versus those who deferred testing to the standard postpartum period. Bivariable statistics including demographics, care team, and postpartum testing/visit attendance were compared between those who received early testing and those who did not using chi-square, Fisher's exact, and t-tests.

RESULTS:

A total of 681 patients with GDM delivered during the study period. Of those who had an early glucose tolerance test ordered (n = 408), 340 (83.3%) completed the test. Among those who did not complete an early glucose tolerance test (ordered and not completed or never ordered), only 104/341 (30.5%) completed any postpartum glucose testing in the first 12 months of postpartum. There were significant differences in characteristics in terms of race/ethnicity, insurance, type of gestational diabetes (A1GDM vs. A2GDM), diabetes medications, obstetric care provider, and delivery mode. Among those who completed early testing, 43.7% of participants had impaired glucose metabolism and 6.5% had values concerning for overt diabetes mellitus. Among those who deferred testing to the standard 6- to 12-week period, 24.0% had impaired glucose metabolism and none had overt diabetes. Those who completed an early glucose tolerance test had a lower rate of postpartum visit attendance compared with those who deferred (75.6 vs. 91.5%, p < 0.01).

CONCLUSION:

In this cohort, when the early glucose tolerance test is offered in clinical practice, adherence rates are higher than when the test is deferred until the postpartum visit. KEY POINTS · Adherence rates with the early glucose tolerance test (GTT) are higher than if the testing is deferred.. · Those who completed an early GTT had a lower rate of postpartum visit attendance compared with those who deferred.. · Offering an in-hospital postpartum GTT can help address low rates of glucose testing postpartum..
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes, Gestational / Postpartum Period / Glucose Tolerance Test Type of study: Observational_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Am J Perinatol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes, Gestational / Postpartum Period / Glucose Tolerance Test Type of study: Observational_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Am J Perinatol Year: 2024 Document type: Article